Technology · 1 sources covering this

Honasa Consumer to acquire majority stake in hair therapy brand Fluence Pharma at Rs 135-crore valuation

Honasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's second acquisition in under a year, following its purchase of Reginald Men in December.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

Economic TimesLean R·2h ago
Honasa Consumer to acquire majority stake in hair therapy brand Fluence Pharma at Rs 135-crore valuation
Honasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's second acquisition in under a year, following its purchase of Reginald Men in December.
Read at Economic Times →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/0a1fd9ad0bc02517b80ce513fa212ac596e176b3"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Honasa Consumer to acquire majority stake in hair therapy brand Fluence Pharma at Rs 135-crore valuation"></iframe>

Honasa Consumer to acquire majority stake in hair therapy brand Fluence Pharma at Rs 135-crore valuation

How 1 sources are covering this

Honasa Consumer to acquire majority stake in hair therapy brand Fluence Pharma at Rs 135-crore valuation

More from Technology

UN chief calls on AI firms to come clean on environmental costs

Square Yards turns unicorn with Rs 900 Cr fundraise

Inside Meta's India investments: First Reliance, now Cred

Kunal Shah’s WhatsApp win; India bourses insulated from AI boom

Reader

Trust & legal

Across the network